Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: * healthy participants who are determined by medical history, physical examination, and clinical judgment of the investigator to be eligible for inclusion in the study. * participants 18 through 55 years of ages. * participants who have received at least 3 doses covid-19 vaccine. * participants with the last prior dose being 90 or more days before visit 1(day 0) or recovered from covid-19 at least 28 days. * participants able to comply with all scheduled visits, laboratory tests and investigator's instruction.

inclusion criteria: * healthy participants who are determined by medical history, physical examination, and clinical judgment of the investigator to be eligible for inclusion in the study. * participants 18 through 55 years of ages. * participants who have received at least 3 doses covid-19 vaccine. * participants with the last prior dose being 90 or more days before visit 1(day 0) or recovered from covid-19 at least 28 days. * participants able to comply with all scheduled visits, laboratory tests and investigator's instruction.

June 19, 2023, noon usa

inclusion criteria: healthy participants who are determined by medical history, physical examination, and clinical judgment of the investigator to be eligible for inclusion in the study. participants 18 through 55 years of ages. participants who have received at least 3 doses covid-19 vaccine. participants with the last prior dose being 90 or more days before visit 1(day 0) or recovered from covid-19 at least 28 days. participants able to comply with all scheduled visits, laboratory tests and investigator's instruction.

inclusion criteria: healthy participants who are determined by medical history, physical examination, and clinical judgment of the investigator to be eligible for inclusion in the study. participants 18 through 55 years of ages. participants who have received at least 3 doses covid-19 vaccine. participants with the last prior dose being 90 or more days before visit 1(day 0) or recovered from covid-19 at least 28 days. participants able to comply with all scheduled visits, laboratory tests and investigator's instruction.